FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049582893> ?p ?o ?g. }

• W3049582893 endingPage "29" @default.
• W3049582893 startingPage "29" @default.
• W3049582893 abstract "This prospective study is one of the largest clinical trials in essential tremor to date. Study findings suggest that individualized non-invasive neuromodulation therapy used repeatedly at home over three months results in safe and effective hand tremor reduction and improves quality of life for many essential tremor patients.Two previous randomized, controlled, single-session trials demonstrated efficacy of non-invasive neuromodulation therapy targeting the median and radial nerves for reducing hand tremor. This current study evaluated efficacy and safety of the therapy over three months of repeated home use.This was a prospective, open-label, post-clearance, single-arm study with 263 patients enrolled across 26 sites. Patients were instructed to use the therapy twice daily for three months. Pre-specified co-primary endpoints were improvements on clinician-rated Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) and patient-rated Bain & Findley Activities of Daily Living (BF-ADL) dominant hand scores. Other endpoints included improvement in the tremor power detected by an accelerometer on the therapeutic device, Clinical and Patient Global Impression scores (CGI-I, PGI-I), and Quality of Life in Essential Tremor (QUEST) survey.205 patients completed the study. The co-primary endpoints were met (p≪0.0001), with 62% (TETRAS) and 68% (BF-ADL) of 'severe' or 'moderate' patients improving to 'mild' or 'slight'. Clinicians (CGI-I) reported improvement in 68% of patients, 60% (PGI-I) of patients reported improvement, and QUEST improved (p = 0.0019). Wrist-worn accelerometer recordings before and after 21,806 therapy sessions showed that 92% of patients improved, and 54% of patients experienced ≥50% improvement in tremor power. Device-related adverse events (e.g., wrist discomfort, skin irritation, pain) occurred in 18% of patients. No device-related serious adverse events were reported.This study suggests that non-invasive neuromodulation therapy used repeatedly at home over three months results in safe and effective hand tremor reduction in many essential tremor patients." @default.
• W3049582893 created "2020-08-21" @default.
• W3049582893 creator A5000787275 @default.
• W3049582893 creator A5003895514 @default.
• W3049582893 creator A5005566965 @default.
• W3049582893 creator A5008303763 @default.
• W3049582893 creator A5009117789 @default.
• W3049582893 creator A5017122855 @default.
• W3049582893 creator A5020655148 @default.
• W3049582893 creator A5027177593 @default.
• W3049582893 creator A5030083453 @default.
• W3049582893 creator A5031250958 @default.
• W3049582893 creator A5031936140 @default.
• W3049582893 creator A5038694807 @default.
• W3049582893 creator A5042573408 @default.
• W3049582893 creator A5043946160 @default.
• W3049582893 creator A5044061507 @default.
• W3049582893 creator A5046518155 @default.
• W3049582893 creator A5052366543 @default.
• W3049582893 creator A5052398485 @default.
• W3049582893 creator A5060500557 @default.
• W3049582893 creator A5060664922 @default.
• W3049582893 creator A5061001628 @default.
• W3049582893 creator A5063689052 @default.
• W3049582893 creator A5067565944 @default.
• W3049582893 creator A5073816587 @default.
• W3049582893 creator A5075310760 @default.
• W3049582893 creator A5078787421 @default.
• W3049582893 creator A5082179442 @default.
• W3049582893 creator A5083598511 @default.
• W3049582893 creator A5085465113 @default.
• W3049582893 creator A5086726410 @default.
• W3049582893 creator A5087762989 @default.
• W3049582893 creator A5091020035 @default.
• W3049582893 creator A5091547171 @default.
• W3049582893 date "2020-08-14" @default.
• W3049582893 modified "2023-09-30" @default.
• W3049582893 title "Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor" @default.
• W3049582893 cites W1758694194 @default.
• W3049582893 cites W1875167095 @default.
• W3049582893 cites W1929499241 @default.
• W3049582893 cites W1987181002 @default.
• W3049582893 cites W1998260351 @default.
• W3049582893 cites W1999393517 @default.
• W3049582893 cites W1999451345 @default.
• W3049582893 cites W2015840305 @default.
• W3049582893 cites W2061004160 @default.
• W3049582893 cites W2074037165 @default.
• W3049582893 cites W2086537275 @default.
• W3049582893 cites W2103903707 @default.
• W3049582893 cites W2125011316 @default.
• W3049582893 cites W2133508641 @default.
• W3049582893 cites W2134098557 @default.
• W3049582893 cites W2143136440 @default.
• W3049582893 cites W2154936861 @default.
• W3049582893 cites W2157192500 @default.
• W3049582893 cites W2168530237 @default.
• W3049582893 cites W2170262105 @default.
• W3049582893 cites W2622548680 @default.
• W3049582893 cites W2763037978 @default.
• W3049582893 cites W2772897268 @default.
• W3049582893 cites W4237839515 @default.
• W3049582893 doi "https://doi.org/10.5334/tohm.59" @default.
• W3049582893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7427656" @default.
• W3049582893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32864188" @default.
• W3049582893 hasPublicationYear "2020" @default.
• W3049582893 type Work @default.
• W3049582893 sameAs 3049582893 @default.
• W3049582893 citedByCount "27" @default.
• W3049582893 countsByYear W30495828932020 @default.
• W3049582893 countsByYear W30495828932021 @default.
• W3049582893 countsByYear W30495828932022 @default.
• W3049582893 countsByYear W30495828932023 @default.
• W3049582893 crossrefType "journal-article" @default.
• W3049582893 hasAuthorship W3049582893A5000787275 @default.
• W3049582893 hasAuthorship W3049582893A5003895514 @default.
• W3049582893 hasAuthorship W3049582893A5005566965 @default.
• W3049582893 hasAuthorship W3049582893A5008303763 @default.
• W3049582893 hasAuthorship W3049582893A5009117789 @default.
• W3049582893 hasAuthorship W3049582893A5017122855 @default.
• W3049582893 hasAuthorship W3049582893A5020655148 @default.
• W3049582893 hasAuthorship W3049582893A5027177593 @default.
• W3049582893 hasAuthorship W3049582893A5030083453 @default.
• W3049582893 hasAuthorship W3049582893A5031250958 @default.
• W3049582893 hasAuthorship W3049582893A5031936140 @default.
• W3049582893 hasAuthorship W3049582893A5038694807 @default.
• W3049582893 hasAuthorship W3049582893A5042573408 @default.
• W3049582893 hasAuthorship W3049582893A5043946160 @default.
• W3049582893 hasAuthorship W3049582893A5044061507 @default.
• W3049582893 hasAuthorship W3049582893A5046518155 @default.
• W3049582893 hasAuthorship W3049582893A5052366543 @default.
• W3049582893 hasAuthorship W3049582893A5052398485 @default.
• W3049582893 hasAuthorship W3049582893A5060500557 @default.
• W3049582893 hasAuthorship W3049582893A5060664922 @default.
• W3049582893 hasAuthorship W3049582893A5061001628 @default.
• W3049582893 hasAuthorship W3049582893A5063689052 @default.
• W3049582893 hasAuthorship W3049582893A5067565944 @default.
• W3049582893 hasAuthorship W3049582893A5073816587 @default.

• next